NL-OMON41651已完成不适用
Functional kidney MRI: developing new sequences - NephrOx
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •age 18 years or over
- •able to give informed consent
排除标准
- •- not willing to be informed about unexpected findings during the study
- •- (possible) pregnancy or lactation
- •- previous donor nephrectomy
- •- known or suspected diseases or conditions that could interfere with the study
- •- use of any prescribed medication (excl. contraceptives) and home use of NSAID*s
- •- body mass index >30
- •- diagnosed hypertension or hypertension (>140/90mmHg) upon screening;For MRI scanning in general:
- •- claustrophobia
- •- metal implants, devices etc.: endoprosthesis, pacemaker, birth control device (IUD), neurostimulator, - - insulin pump, intra-ocular metal particles, metal heart valve, cochlear implant
- •- previous severe allergic reaction to contrast medium (only when contrast is used, healthy subjects phase 1);For GFR measurement (applicable to healthy subjects only)
- •- iodine allergy
研究者
相似试验
已完成
不适用
Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 StudyC3 GlomerulonephritisC3 GlomerulopathyImmune Complex Membranoproliferative GlomerulonephritisIC-MPGNDense Deposit DiseaseNCT03723512Mario Negri Institute for Pharmacological Research7
尚未招募
不适用
Effect of bone tunnel position on outcome of anterior cruciate ligament reconstructioCTRI/2021/09/036470Dept of Orthopaedics
已完成
不适用
Advanced MRI in renal tumoursKidney cancerrenal tumours10038430NL-OMON40717niversitair Medisch Centrum Sint Radboud80
尚未招募
不适用
MRI Technical Development and Applications in Kidney DiseaseChronic Kidney DiseasesKidney TransplantationDialysisCognition DisordersNCT02421497University of Minnesota180
已完成
不适用
sing functional magnetic resonance imaging to investigate the efficacy of menthol in chemotherapy induced peripheral neuropathy (CIPN)Chemotherapy Induced Peripheral Neuropathy (CIPN)CancerISRCTN69917256Academic and Clinical Centre Office for Research and Development (ACCORD) (UK)32